Stanford University
Showing 101-200 of 310 Results
-
Yang Hu, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Xiaojing Huang
Postdoctoral Scholar, Ophthalmology
BioXiaojing earned her Bachelor of Science in Optical Engineering, graduating cum laude, from the University of Rochester in 2018. Continuing her academic journey at the same institution, she began her graduate studies in optics in the spring of 2019. Under the supervision of Professors Julie Bentley and Alfredo Dubra, she completed her PhD in 2024. The same year, Xiaojing joined Stanford University as a postdoctoral researcher, furthering her exploration and contributions to the field of adaptive optics retinal imaging.
-
Jia-Horung Hung
Affiliate, Ophthalmology Research/Clinical Trials
Visiting Scholar, Ophthalmology Research/Clinical TrialsBioDr. Jia-Horung Hung is an ophthalmologist and a retina and glaucoma specialist. He is a board-certified ophthalmologist and an active member of several professional societies, including The Ophthalmological Society of Taiwan, American Academy of Ophthalmology, Taiwan Retinal Society, and Taiwan Ocular Inflammation Society (TOIS), where he served as the Secretary General from 2020 to 2023. Dr. Hung’s research is dedicated to developing innovative treatments for ocular diseases, with a focus on ocular inflammation and infection, innovative surgical techniques, inhereditary ocular diseases, and ophthalmic big-data analysis. He has received numerous teaching awards since becoming a clinical assistant professor at National Cheng Kung University in 2021. His award includes Young investigator research award in clinical medicine of School of Medicine, National Cheng Kung University; Best Presentations in different academic meetings; Best Teaching Faculty in the University; Gold Medal and Best Hardware of the 2020 International Genetically Engineered Machine (iGEM) competition. His laboratory study mainly focuses on age-related macular degeneration, inhereditary ocular diseases, and antimicrobial photodynamic therapy for eye infections. Dr. Jia-Horung Hung is a visiting scholar at Professor Quan Dong Nguyen’s lab in Stanford University since November 2023, where he is receiving training on ocular inflammatory diseases and working as an affiliate of Ophthalmology Research/Clinical Trials.
-
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science to design and develop human-centric technologies. Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank. -
Eubee Baughn Koo
Clinical Assistant Professor, Ophthalmology
BioDr. Koo is a board-certified ophthalmologist with the Byers Eye Institute at Stanford Health Care and a clinical assistant professor in the Department of Ophthalmology.
Dr. Koo diagnoses and treats a wide range of eye conditions, such as blepharitis, macular degeneration, diabetic retinopathy, farsightedness, cataracts, and glaucoma. She performs a range of surgical procedures, including cataract surgery, chalazia excisions, and laser glaucoma surgery. Dr. Koo creates a comprehensive, personalized treatment plan for each of her patients.
In addition to her clinical responsibilities, Dr. Koo is involved in the education and oversight of medical students, interns, and Ophthalmology residents spanning all settings from the classroom to the clinic, operating room, and the hospital.
Dr. Koo researches best practices in ophthalmologic care. Her research has included case studies to evaluate treatments in adults and children.
Dr. Koo’s work has been published in peer-reviewed journals, including Retina and the Journal of Pediatric Ophthalmology and Strabismus. She has been invited to moderate and present at regional, national, and international meetings, including the World Ophthalmology Congress. -
Euna Koo, MD
Clinical Associate Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Koo is an ophthalmologist specializing in pediatric ophthalmology, retinopathy of prematurity (ROP) and adult strabismus. She received her ophthalmology training at UC San Francisco and then her fellowship training in pediatric ophthalmology and adult strabismus at Boston Children's Hospital affiliated with Harvard Medical School. She has been board certified by the American Board of Ophthalmology since 2016. Her practice reflects her clinical interests in pediatric ophthalmology (strabismus, amblyopia, pediatric cataracts, and ROP) and in adult strabismus.
She utilizes Botox in management of adult and pediatric strabismus. She also uses hidden adjustable sutures in children and adults to optimize alignment of eyes with surgery. Muscles can be adjusted up to 7-10 days after surgery.
She also has an interest in teaching medical students and residents and improving surgical training. -
Edward Korot
Adjunct Clinical Instructor, Ophthalmology
BioI’m a vitreoretinal surgeon guided by the goal of maximally scaling improvements in patients’ lives through technology.
My work involves medical AI validation, guideline development, safety, quantifying model uncertainty, AI-driven pharmaceutical trial recruitment, partner management, and UX research.
Currently, I’m an adjunct faculty at Stanford, and practicing in Michigan. When not working, you can find me doing yoga, practicing drone photography and playing tennis. -
Andrea Lora Kossler, MD, FACS
Assoc Professor of Ophthalmology
Current Research and Scholarly InterestsThyroid Eye Disease
Adenoid Cystic Carcinoma of the Lacrimal Gland
Lacrimal Gland Stimulation for the Treatment of Dry Eyes
Neurostimulation
Orbital Tumors
Floppy Eyelid Syndrome and Obstructive Sleep Apnea -
Bartlomiej Kowalski
Software Dvlpr 3, Ophthalmology Research/Clinical Trials
BioI am a senior software engineer in the Dubra Lab at The Byers Eye Institute, where I work on developing novel ophthalmic imaging instrumentation for improving the understanding, diagnosing and management of eye disease.
My interest in computer science started early in life and led me to obtain master’s degree at Czestochowa University of Technology (Poland). After graduating, I contributed to the advancing of spectral domain optical coherence tomography (OCT) and pioneering of swept-source OCT for retinal imaging as part of Canon Ophthalmic Technologies (Poland). This work resulted in two commercially successful instruments, the Xephilio OCT-A1 and the Xephilio OCT-S1, which are sold worldwide.
My current work focuses on innovations that allow the translation of Adaptive Optics Ophthalmoscopy from a research tool into a mature technology that improves eye care. -
Karteek Kunala
Research Engineer, Ophthalmology Research/Clinical Trials
BioMy current interests are in development of design and instrumentation of pre-clinical vision devices, to conduct non-invasive in vivo retinal imaging. I studied Physics with a concentration in optics during my time at University of Hyderabad, India and received a bachelors and masters degree in 2014. I then moved to USA to continue working in the field of optics at University of North Carolina at Charlotte to pursue my PhD, working on nanofabrication of broadband anti-reflective structures. My interest in vision science started with my job at University of Rochester as a research scientist, where I was involved in developing optical imaging tools using adaptive optics to study retinal diseases. My work was focused on development of fluorescence lifetime imaging techniques in humans and two photon fluorescence microscopy in mouse.
-
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
-
Wen-Shin Lee, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Wen-Shin Lee, MD, is a Clinical Assistant Professor of Ophthalmology at the Stanford University School of Medicine, and the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley.
Dr. Lee is a fellowship trained, board certified ophthalmologist with expertise in the medical and surgical management of glaucoma, cataracts, and anterior segment disease. Working with patients to provide individually tailored treatment plans, he incorporates the full spectrum of conventional and minimally invasive glaucoma surgeries. He also performs complex and refractive cataract surgery utilizing advanced technology intraocular lenses. His goal is to provide the highest level of care to each patient with evidence-based medicine and cutting-edge technology.
In addition to his clinical practice, Dr. Lee is actively involved in clinical research and education at the Stanford University School of Medicine. He is a principal investigator and co-investigator on multiple clinical trials and research studies with a focus on glaucoma. He is the resident glaucoma rotation director for the Stanford ophthalmology residency and co-director of the Bay Area Ophthalmology Course. He has developed and leads microsurgical training programs for medical students, residents, and fellows at Stanford. In addition, he serves on the Education Committee and Clinical Competency Committee for the Stanford Department of Ophthalmology.
Dr. Lee was educated at the University of California, Berkeley, where he graduated summa cum laude with a degree in molecular and cell biology. He then received his medical degree at Harvard Medical School, followed by his ophthalmology residency at the Stanford University School of Medicine, and glaucoma fellowship at the Jules Stein Eye Institute at UCLA. Upon completion of his training he joined the clinical faculty at Stanford.
Dr. Lee serves as the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley, where his goal is to deliver world class eye care to the Tri-Valley region and beyond. -
Theodore Leng, MD, FACS
Associate Professor of Ophthalmology and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cellular, biologic and laser-based therapies for macular degeneration. He also has an active program in imaging informatics and deep learning to perform big data analyses of retinal scans to identify patients who are at risk for retinal disease deterioration. The end goal is earlier detection and rapid treatment to maximize visual outcomes.
Dr. Leng is considered a leading expert on optical coherence tomography (OCT) and OCT-based angiography (OCTA), a non-invasive and non-contact imaging technique for the retina. He is also considered a key opinion leader in artificial intelligence and data science. -
Y. Joyce Liao, MD, PhD
Stanford Medicine Professor of Ophthalmology and Professor of Neurology
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Charles C. Lin, MD
Clinical Associate Professor, Ophthalmology
Current Research and Scholarly InterestsDr. Lin conducts clinical trials focused on cornea transplantation, corneal edema, and cornea infections at Stanford. His research interests include improving the success and safety of cutting edge surgeries such as ultra-thin DSAEK, DMEK, DALK, and DSO. He is actively researching surgical therapies for corneal edema and Fuchs' Dystrophy. He is among a handful of cornea specialists nationwide with extensive experience using intraoperative OCT imaging to perform cornea transplants.
-
Wendy Liu, MD, PhD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Liu's research interests include the role of mechanosensation in the eye as it relates to the pathophysiology of glaucoma, with the goal of finding new druggable targets in glaucoma treatment.
-
Cassie Ann Ludwig, MD, MS
Assistant Professor of Ophthalmology (Research/Clinical Trials)
Masters Student in Biomedical Data Science, admitted Autumn 2023Current Research and Scholarly InterestsMy research at present focuses on better understanding high and pathologic myopia and their retina sequelae (retinal detachments, myopic traction maculopathy, myopic macular degeneration) through informatics and data-driven research. My goal is to make discoveries within the field of Ophthalmology that will impact the rest of medicine, taking advantage of our ready access to the only visible portion of the central nervous system.
-
Vinit B. Mahajan, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur focus is the development of personalized medicine for eye diseases through translation of our discoveries in proteomics, genomics, and phenomics in humans, mice and tissue culture models.
-
Edward Manche, MD
Professor of Ophthalmology
BioEdward E. Manche, MD is Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Service at Stanford University School of Medicine. He received his medical degree from Albert Einstein College of Medicine and completed residency training at the University of Medicine and Dentistry at New Jersey where he served as Chief Resident. He completed a two-year fellowship in Cornea and Refractive Surgery at the Jules Stein Eye Institute at UCLA.
Dr. Manche is a fellow of the American Academy of Ophthalmology and received its Achievement Award in 2003 and its Senior Achievement Award in 2014. He was elected to active membership in the American Ophthalmological Society in 2011, and is recognized in Best Doctors in America and Guide to America's Top Physicians. He serves on the editorial boards of the American Journal of Ophthalmology, Journal of Ophthalmology, Clinical and Experimental Ophthalmology and Journal of Refractive Surgery.
He lectures widely on topics in cornea and refractive surgery and has published over 130 peer-reviewed articles and 30 book chapters. -
Michael Marmor, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsResearch concerns diseases of retinal function, techniques of clinical electrophysiology, and experimental studies on retinal pigment epithelial (RPE) function including fluid transport and retinal adhesiveness. Other studies consider aspects of vision and art, and ophthalmic history.
Published over 300 journal articles, chapters, books (only selected articles listed). -
Bethlehem Mekonnen, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Mekonnen is a board-certified, fellowship-trained ophthalmologist with the Byers Eye Institute at Stanford Health Care. She is also a clinical assistant professor of medicine in the Department of Ophthalmology.
Dr. Mekonnen diagnoses and treats a wide range of eye conditions, including cataracts, corneal and external eye diseases. She creates an individual, comprehensive care plan for each of her patients.
Dr. Mekonnen’s clinical research interests include exploring the most effective medical and surgical therapies for patients with corneal and external eye diseases. She has researched and published on outcomes of macular edema, described a novel surgical technique for severe ocular surface disease and described a possible new ophthalmic manifestation of a rare congenital disorder called Cobb syndrome.
Dr. Mekonnen has published work in the American Journal of Ophthalmology, Cornea: The Journal of Cornea and External Disease, and the Journal of Ophthalmic Inflammation and Infection. She has presented to her peers at the Association for Research in Vision and Ophthalmology, Women in Ophthalmology (WIO) Summer Symposium, and the Annual GlaxoSmithKline Women in Science Conference.
Dr. Mekonnen is a member of the American Academy of Ophthalmology. -
Artis A. Montague, MD, PhD
Clinical Professor, Ophthalmology
Current Research and Scholarly InterestsMulticenter Catalys Consortium Trial - To compare femtosecond laser assisted cataract surgery with conventional cataract surgery
-
Darius M. Moshfeghi, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Moshfeghi leads the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP network) and the Pediatrix-Stanford collaboration TeleROP. Between these 2 screening programs, nearly 2% of United States neonatal intensive care units are being provided telemedicine screening services through Stanford University.
-
Heather E. Moss, MD, PhD
Professor of Ophthalmology and of Neurology
Current Research and Scholarly InterestsI am a clinician scientist with a background in engineering, epidemiology and neuro-ophthalmology. In my research, I combine tools from these disciplines with the goal of understanding and preventing vision loss from optic nerve diseases. My focus is on papilledema, the swelling of the optic nerve head due to elevation in intracranial pressure, which we are characterizing using electrophysiological and imaging techniques. Other areas of interest are peri-operative vision loss and optic neuritis.
-
Prithvi Mruthyunjaya, MD, MHS
Professor of Ophthalmology and, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
David Myung, MD, PhD
Associate Professor of Ophthalmology and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsNovel biomaterials to reconstruct the wounded cornea
Mesenchymal stem cell therapy for corneal and ocular surface regeneration
Engineered biomolecule therapies for promote corneal wound healing
Telemedicine in ophthalmology -
Ramsudha Narala
Clinical Assistant Professor, Ophthalmology
BioDr. Ramsudha Narala is a board certified ophthalmologist who specializes in vitreoretinal surgery and ocular oncology. Dr. Narala grew up in Fresno, California and following high school, she attended the 8 year combined undergraduate-medical school program at Saint Louis University in Saint Louis, Missouri.
After medical school, she completed her ophthalmology residency at Kresge Eye Institute in Detroit, MI, where she received the best resident teacher award and highest resident ophthalmic knowledge assessment program exam score award. She then joined the University of Southern California in Los Angeles, California for a 2 year vitreoretinal surgery fellowship where she was elected chief vitreoretinal surgery fellow. Following completion of vitreoretinal surgery fellowship, she pursued an advanced training fellowship in ocular oncology at Byers Eye Institute at Stanford University.
Dr. Narala has authored many peer-reviewed scientific publications and textbook chapters on vitreoretinal diseases and ocular oncology. She is also dedicated to education and teaching medical students, residents, and fellows.
Dr. Narala's clinical practice is mainly based at Santa Clara Valley Medical Center. -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Ke Ning
Postdoctoral Scholar, Ophthalmology
BioDr. Ning currently joins Dr. Yang Sun’s lab as a postdoctoral fellow at Dept. of Ophthalmology, Stanford University. Her current research interests include cilia-mediated signaling in RPE-related diseases and glaucoma. Dr. Ning received her MD at Xiamen University in China and completed her internship at Zhongshan Hospital Affiliated with Xiamen University. Her long-term research interest is to understand primary cilia roles in ocular development and how alterations in cilia-related gene expression contribute to eye diseases. Her further goal is to be a physician-scientist and to translate scientific discoveries to patient therapies. Some of her hobbies are cycling, reading, and skiing.
-
Amir Norouzpour
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
Current Role at StanfordResearch Scientist
